A nuclease with a RecJ-piwi domain and its application in random genome mutagenesis

By providing the cleavage of double-stranded DNA by BaRecJ-piwi nuclease of RecJ-piwi domain, the problem of low genomic mutation efficiency in advanced organisms is solved, efficient mutations in a wide range of hosts are achieved, and synthetic organisms are promoted Study research.

CN116064475BInactive Publication Date: 2024-11-15FIRST INSTITUTE OF OCEANOGRAPHY MNR +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202211219015.8
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2022-10-07
Publication Date
2024-11-15
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

The existing global mutation methods are difficult to apply in higher organisms, and it is difficult to achieve efficient genomic random mutations in plants, animals and other organisms, which limits the development of synthetic biology.

Method used

Provides a nuclease with a RecJ-piwi domain, BaRecJ-piwi with an amino acid sequence of SEQ ID NO:1, which can cleave double-stranded DNA, induce random mutations in the genome, build a mutant library, and recombination Expression vectors achieve their expression in different organisms.

Benefits of technology

Efficient genomic random mutations in a wide range of hosts, including plants and animals, are achieved, resulting in rich mutation types, significantly improving the mutation efficiency and breadth of the spectrum, and promoting synthetic biology research.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN116064475B_ABST
    Figure CN116064475B_ABST
Patent Text Reader

Abstract

The present invention provides a nuclease with a RecJ‑piwi domain and its application in random mutation of a genome, and the amino acid sequence of the provided nuclease is SEQ ID NO: 1. The nuclease provided by the present invention can induce random mutations of the global genome, and compared with traditional mutagenesis methods, it has the characteristics of higher efficiency and wider spectrum. Compared with the current global methods, the nuclease provided by the present invention has the widest host range, and can work not only in lower organisms, but also in higher organisms including plants and animals. Using the nuclease provided by the present invention, a large number of mutants of different genotypes can be quickly obtained, which is conducive to clarifying the relationship between metabolic pathways and active molecules, and thus has the potential to promote synthetic biology.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the technical field of gene editing, and specifically relates to a nuclease with a RecJ-piwi domain and an application thereof in random genome mutation. Background Art

[0002] Adaptive laboratory evolution (ALE) is a powerful method to promote the optimization of microbial cell regulation and metabolic networks. By improving mutation efficiency, ALE accelerates the timescale for the discovery of biomolecules with desired properties. Compared with in vitro mutagenesis methods, in vivo mutagenesis methods are more suitable for the application of ALE. In vivo mutagenesis does not require extracellular DNA mutations for transformation expression, and mutations can be easily continued during propagation, resulting in a more diverse mutant library.

[0003] Compared with other traditional mutagenesis methods, vector-based global mutagenesis methods have certain advantages in terms of mutagenic titer and mutagenic spectrum. However, current global mutation methods are all based on interfering with genome replication correction and reducing the accuracy of repair, which means that if such methods are used for mutation, it is necessary to understand the replication-related genes in the target strain. At present, such methods are only used in mutation studies of microorganisms and are difficult to apply in higher organisms. Summary of the invention

[0004] The purpose of the present invention is to provide a nuclease with a RecJ-piwi domain and its application in random genome mutation. The provided nuclease can cut double-stranded DNA to produce rich mutation types, and can be used to induce mutations and construct a mutant library.

[0005] The present invention first provides a nuclease for random genome mutation, wherein the nuclease comprises:

[0006] 1) a nuclease having an amino acid sequence of SEQ ID NO: 1;

[0007] (SEQ ID NO: 1);

[0008] 2) Proteases derived from 1) by substituting, deleting or adding one or more amino groups to the amino acids in 1);

[0009] Another aspect of the present invention also provides a gene for encoding the above-mentioned nuclease, a specific sequence of which is as follows:

[0010]

[0011] Another aspect of the present invention provides an inducible expression vector, wherein the recombinant vector carries a gene fragment for encoding the above-mentioned nuclease.

[0012] The present invention also provides a use of the nuclease, which is the use in performing random mutation on a genome;

[0013] In another aspect, the present invention provides a method for constructing a mutant library, wherein the method comprises using the above-mentioned nuclease to perform random mutation of the genome to construct the library;

[0014] The mutant library, as a specific description of the embodiment, is a mutant library for screening Escherichia coli tolerant to n-butanol;

[0015] The mutant library, as another specific description of the embodiment, is a mutant library for screening acetic acid-tolerant Saccharomyces cerevisiae;

[0016] The present invention also provides a mutagenesis system for genome mutation, wherein the system contains the above nuclease.

[0017] The nuclease provided by the present invention can induce random mutations in the global genome, and compared with the traditional mutagenesis method, it has the characteristics of higher efficiency and wider spectrum. Compared with the current global method, the nuclease provided by the present invention has the widest host range, and can work not only in lower organisms, but also in higher organisms including plants and animals. Using the nuclease provided by the present invention, a large number of mutants with different genotypes can be quickly obtained, which is conducive to clarifying the relationship between metabolic pathways and active molecules, and thus has the potential to promote synthetic biology. BRIEF DESCRIPTION OF THE DRAWINGS

[0018] Figure 1 :The effect of RecJ-piwi protein on the lethality of Escherichia coli;

[0019] Figure 2 :Analysis of the efficiency of BaRecJ-piwi-induced antibiotic-tolerant mutation in Escherichia coli;

[0020] Figure 3 :Analysis of mutation types of antibiotic-resistant rpoB;

[0021] Figure 4 : Analysis of the mutation base sites of antibiotic resistance;

[0022] Figure 5 :Analysis of BaRecJ-piwi-induced Escherichia coli mutation tolerance to n-butanol;

[0023] Figure 6:Based on the analysis of the mutation of BaRecJ-piwi-induced acetic acid resistance in Saccharomyces cerevisiae;

[0024] Figure 7 : Analysis of zebrafish mutants based on microinjection of BaRecJ-piwi, where the top picture is a photo of control zebrafish, and the bottom three pictures are photos of zebrafish mutants. DETAILED DESCRIPTION

[0025] The applicant discovered a nuclease PIWI with a PIWI domain in previous studies, and the amino acid sequence is as follows:

[0026] MKQLAPFGVSNPTPKIMLQQANIGEMKKIGSEANHLKIQFKQNGSSLDGIGFHFGYVYEQMSVQDRVSAVGTLSINEWNGHIKPQLMIEDIAVTDWQLFDWRSVQKLRLEDKLKLISLPTQYLIAFNDETKVKLKLENEQIWTREQLSHIDSFENAAVVL LDLPASEQEIKQLFADKGRPSQIFCLFYQEEDSFFSASPNRETFKWFYAFLRKQKKFNLNEQGMKLISYKGWSKESVKFMVEVFVELNFIRQENGWLIIEENPEKKSLTDSVAFQRKENQRTLENDFVYSSFEHLKQLFTTIFEQNTNESTIKETV(SEQ ID NO:3,);

[0027] It can bind to different phosphorylated small DNA / RNA, act as an endonuclease on multiple specific sites, and perform gene editing.

[0028] Although the nuclease PIWI with a PIWI domain can cut DNA double strands under mild conditions of 37°C, making genetic engineering operations more convenient; its efficiency in global random mutations of the genome is very low.

[0029] Based on the analysis of the genome sequence of Bacillus alcalophilus, it was found that the nuclease BaRecJ-piwi with a RecJ-piwi domain and a sequence of SEQ ID NO: 1 has the effect of inducing random mutations in the global genome.

[0030] In one aspect, the present invention protects the nuclease BaRecJ-piwi having an amino acid sequence of SEQ ID NO: 1, and a derivative enzyme of the nuclease;

[0031] The derivative enzyme may be an enzyme that replaces, deletes, or adds one or more amino groups to the nuclease BaRecJ-piwi having an amino acid sequence of SEQ ID NO: 1, and maintains functions similar to those of the nuclease BaRecJ-piwi.

[0032] Another aspect of the present invention provides a recombinant expression vector for recombinantly expressing the above-mentioned nuclease BaRecJ-piwi.

[0033] One use of the nuclease BaRecJ-piwi provided by the present invention is its application in random mutation of genomes; the provided nuclease can cut double-stranded DNA, thereby generating a rich variety of mutation types, and can be used to induce mutations and construct a mutant library.

[0034] In another aspect, the present invention provides a method for constructing a mutant library, wherein the method comprises using nuclease BaRecJ-piwi to perform random mutation of the genome to construct the library;

[0035] The invention also provides a mutagenesis system for genome mutation, wherein the system contains nuclease BaRecJ-piwi.

[0036] The nuclease BaRecJ-piwi of the present invention is used to construct a mutagenesis system with induction function and capable of improving the efficiency of adaptive evolution. Mutagenesis produces many mutation types that cannot be produced by traditional methods, and more excellent traits can be obtained.

[0037] The present invention is described in detail below in conjunction with embodiments and drawings.

[0038] Example 1 Effect of BaRecJ-piwi expression on host survival rate

[0039] Design specific primers for BaRecJ-piwi, and use high-fidelity enzymes for PCR amplification. Gel recovery of the amplified product and sequencing. Treat the plasmid with NdeI and XhoI restriction endonucleases, and recover the enzyme-cut fragments. Use homologous recombination to connect the amplified fragment and the plasmid to obtain the pACYCBaRecJ-piwi-piwi plasmid. Transform E.coli BL21 (DE3) with pACYCBaRecJ-piwi-piwi or pACYCDuet-1, prepare a bacterial suspension, spread it on an LB agar plate containing IPTG (0.1mM) and chloramphenicol (50μg / ml), culture at 37°C, and count CFU. Pick the above-mentioned single colonies containing pACYC BaRecJ-piwi or pACYCDuet-1 and inoculate them into LB medium containing IPTG (0.1mM) and chloramphenicol (50μg / ml), and culture them at 37°C with shaking. Samples were collected every hour for 8 hours. Centrifuged at 13000×g for 3 minutes, washed 3 times, and IPTG was removed. The resuspension was spread on LB agar plates and cultured at 37°C overnight to determine CFU ( Figure 1 The CFU count of plasmid pACYCBaRecJ-piwi was defined as 1, and the CFU count of pACYCBDuet1-1 was normalized to this value to determine the effect of BaRecJ-piwi on survival rate. Figure 1 The results showed that when BaRecJ-piwi was induced to express, a large number of hosts would die, and the survival rate was significantly reduced compared with the control, which was only 1.3% of the control.

[0040] Example 2 Efficiency of BaRecJ-piwi in the Rifampicin-resistant Mutation of Escherichia coli

[0041] Subclone BaRecJ-piwi into pGEX-4T-1 to construct an inducible expression vector (named: pGEX4T-BaRecJ-piwi); prepare chemically competent Escherichia coli MG1655, transform the constructed vector into Escherichia coli, and select transformants;

[0042] Pick out the transformants containing pGEX4T-BaRecJ-piwi, use the empty vector pGEX-4T-1 without BaRecJ-piwi-piwi gene as the control, and inoculate 2YT medium. Cultivate until OD = 0.5-0.8, add the inducer IPTG to a final concentration of 0.2mM, and induce expression at 16℃ for 24h. Transfer the induced expression cells to 2YT medium at a 1-3% inoculation amount, and culture overnight at 30℃ for 18-21h. After gradient dilution, spread on 2YT plates and 2YT plates containing rifampicin (rifampicin content 100μg / ml), and calculate the mutation efficiency ( Figure 2 ). The results showed that after random shearing of BaRecJ-piwi-piwi, the host obtained highly resistant rifampicin mutants, and its mutation efficiency was 125 times that of the control. The mutation efficiency calculation formula was: 2YT plate CFU of antibiotic / 2YT plate CFU. The mutation efficiency of the sample was 125 times that of the control.

[0043] Example 3 Analysis of mutation types of rifampicin-resistant mutants

[0044] A single colony on the rifampicin plate was picked, placed in 100 μL of distilled water, shaken vigorously and then incubated at 100°C for 15 min. PCR amplification was performed using primers AB1 (5′-AATGTCAAATCCGTGGCGTGAC-3′) and AB2 (5′-TTCACCCGGATACATCTCGTCTTC-3′) to obtain an rpoB fragment containing clusters I and II. Each fragment was sequenced twice using primers AB3 (5′-CGGAAGGCACCGTAAAAGACAT-3′) and AB4 (5′-CGTGTAGAGCGTGCGGTGAAA-3′) (3).

[0045] like Figure 3 The results showed that after BaRecJ-piwi induced host mutations, the mutation types it produced were more diverse than spontaneous mutations. The mutation spectrum of the control and pGEX4T-BaRecJ-piwi was evaluated by sequencing the rifampicin-resistant rpoB allele in mutant MG1655. The control produced a narrow mutation spectrum that was strongly biased towards CT mutations. In contrast, pGEX4T-BaRecJ-piwi showed a broader mutation spectrum with a more even distribution, including a significant increase in mutation types of AC, AT, and CG. Figure 4 Indicates the position distribution of the mutant bases on the gene. MP6 is the most efficient mutagenesis method at present, but it can only obtain 24 base substitution mutations, while the present invention can obtain 52 base substitution mutations in the same rpoB region.

[0046] Example 4 Analysis of n-butanol-tolerant mutants of Escherichia coli based on BaRecJ-piwi

[0047] The transformed strain was cultured overnight, transferred to 2YT medium at a 1% inoculation rate, cultured to OD600 = 0.4-0.5, cooled to 16°C, and IPTG was added to a final concentration of 0.2mM, and induced for 24 hours. Transferred to fresh 2YT medium at a 1% transfer rate, cultured at 30°C with shaking for 24 hours, spread an appropriate amount on a 2YT plate medium containing 2% n-butanol, and cultured inverted for 72 hours. Randomly pick colonies and culture them in 1% n-butanol for 48 hours. The results showed that the mutated strain had an average OD value of 1.11 in 1% n-butanol, while the control had only 0.12 ( Figure 5 ).

[0048] Example 5 Analysis of acetic acid-resistant mutants of Saccharomyces cerevisiae based on BaRecJ-piwi

[0049] The yeast strain was inoculated into YPDA medium and cultured at 30°C. The cells were collected by centrifugation and resuspended in SC-ura culture. The OD value was adjusted to 0.4-0.5. Galactose and raffinose were added for induction culture at 16°C for 48 hours. SC-ura was further transferred at an inoculation rate of 3-5% and induced at 30°C for 72 hours. The induced yeast was transferred to YPDA medium containing 0.4% acetic acid and counted. The tolerance of mutant cells to acetic acid was evaluated. After two rounds of evolution, the strain based on the BaRecJ-piwi-piwi mutation had preferential growth ability in acetic acid. After 3-5 days of culture, the OD600 could reach 1.5 in an acetic acid concentration of 1.0%, while the control could not grow between 0.4% and 0.6% ( Figure 6 ).

[0050] Example 6 Analysis of zebrafish mutants based on BaRecJ-piwi-piwi

[0051] BaRecJ-piwi-piwi protein was obtained by heterologous expression and diluted to 250-300pg / nl with phosphate buffer. Male and female zebrafish were placed in a spawning tank at a ratio of 1:1-2, separated by a partition, overnight, and the partition was removed after 10 minutes of illumination the next day. Fertilized eggs were collected after 0.5 hours, and the embryos were cultured in a 28.5℃ constant temperature incubator. BaRecJ-piwi protein was injected into fertilized eggs by microinjection, with 1-2nL injected per egg. At the same time, 100 embryos from the same batch injected with an equal volume of DEPC water were kept as controls ( Figure 7 The results showed that after 24 hours of culture, there was no mortality in the control group, while the mortality rate of the sample group was as high as 50%. Further observations showed that no deformed fry were found in the control group, while the sample injected with BaRecJ-piwi-piwi protein had a 10% deformity rate.

[0052] In summary, the nuclease provided by the present invention can induce random mutations in the global genome and has application prospects in constructing mutant libraries.

Claims

1. A use of a nuclease in random mutation of a genome, characterized in that: The nuclease: A nuclease having an amino acid sequence of SEQ ID NO: 1; The application is limited to inducing mutations in E. coli or Saccharomyces cerevisiae.

2. A method for constructing a mutant library, characterized in that: The method described is to use nuclease to perform random genome mutation to construct a library; the nuclease: A nuclease having an amino acid sequence of SEQ ID NO: 1; The method is to construct a mutant library of Escherichia coli or a mutant library of Saccharomyces cerevisiae.